Literature DB >> 26757035

Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.

Gianfranco Spalletta1, Luca Cravello1, Walter Gianni2, Federica Piras1, Mariangela Iorio1, Claudia Cacciari1, Anna Rosa Casini3, Chiara Chiapponi1, Giuseppe Sancesario4, Claudia Fratangeli1, Maria Donata Orfei1, Carlo Caltagirone1,4, Fabrizio Piras1,5.   

Abstract

Homotaurine supplementation may have a positive effect on early Alzheimer's disease. Here, we investigated its potential neuroprotective effect on the hippocampus structure and episodic memory performances in amnestic mild cognitive impairment (aMCI). Neuropsychological, clinical, and neuroimaging assessment in 11 treated and 22 untreated patients were performed at baseline and after 1 year. Magnetic resonance data were analyzed using voxel-based morphometry to explore significant differences (Family Wise Error corrected) between the two groups over time. Patients treated with homotaurine showed decreased volume loss in the left and right hippocampal tail, left and right fusiform gyrus, and right inferior temporal cortex which was associated with improved short-term episodic memory performance as measured by the recency effect of the Rey 15-word list learning test immediate recall. Thus, homotaurine supplementation in individuals with aMCI has a positive effect on hippocampus atrophy and episodic memory loss. Future studies should further clarify the mechanisms of its effects on brain morphometry.

Entities:  

Keywords:  Amnestic mild cognitive impairment; episodic memory; hippocampus; homotaurine; structural magnetic resonance imaging; tramiprosate

Mesh:

Substances:

Year:  2016        PMID: 26757035     DOI: 10.3233/JAD-150484

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Daisuke Asaoka; Jinzhong Xiao; Tsutomu Takeda; Naotake Yanagisawa; Takahiro Yamazaki; Yoichiro Matsubara; Hideki Sugiyama; Noemi Endo; Motoyuki Higa; Koji Kasanuki; Yosuke Ichimiya; Shigeo Koido; Kazuya Ohno; Francois Bernier; Noriko Katsumata; Akihito Nagahara; Heii Arai; Toshifumi Ohkusa; Nobuhiro Sato
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms.

Authors:  Md Jakaria; Shofiul Azam; Md Ezazul Haque; Song-Hee Jo; Md Sahab Uddin; In-Su Kim; Dong-Kug Choi
Journal:  Redox Biol       Date:  2019-05-21       Impact factor: 11.799

Review 3.  Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review.

Authors:  Nobutaka Masuoka; Chenxu Lei; Haowei Li; Tatsuhiro Hisatsune
Journal:  Nutrients       Date:  2021-01-27       Impact factor: 5.717

4.  Effects of Citicoline, Homotaurine, and Vitamin E on Contrast Sensitivity and Visual-Related Quality of Life in Patients with Primary Open-Angle Glaucoma: A Preliminary Study.

Authors:  Pier Franco Marino; Gemma Caterina Maria Rossi; Giuseppe Campagna; Decio Capobianco; Ciro Costagliola
Journal:  Molecules       Date:  2020-11-29       Impact factor: 4.411

5.  Multicenter, Prospective, Randomized, Single Blind, Cross-Over Study on the Effect of a Fixed Combination of Citicoline 500 mg Plus Homotaurine 50 mg on Pattern Electroretinogram (PERG) in Patients With Open Angle Glaucoma on Well Controlled Intraocular Pressure.

Authors:  Gemma Caterina Maria Rossi; Teresa Rolle; Annalisa De Silvestri; Dario Sisto; Alberto Mavilio; Alessandra Venera Mirabile; Alessia Paviglianiti; Beatrice Strano; Erica Picasso; Gian Maria Pasinetti; Giovanni Milano; Giulio Ruberto
Journal:  Front Med (Lausanne)       Date:  2022-04-29

6.  Editorial: Rising stars in aging psychiatry: 2022.

Authors:  Gianfranco Spalletta; Vanessa Pipino; Federica Piras
Journal:  Front Psychiatry       Date:  2022-07-25       Impact factor: 5.435

Review 7.  A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders.

Authors:  Sagrario Manzano; Luis Agüera; Miquel Aguilar; Javier Olazarán
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

8.  Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment.

Authors:  Paola Bossù; Francesca Salani; Antonio Ciaramella; Eleonora Sacchinelli; Alessandra Mosca; Nerisa Banaj; Francesca Assogna; Maria Donata Orfei; Carlo Caltagirone; Walter Gianni; Gianfranco Spalletta
Journal:  Front Aging Neurosci       Date:  2018-11-02       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.